---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-065710"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:50:25.986242+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cadrenal director resigns; 2025 annual meeting set for Sept 24, proposal deadline July 28

## Summary
- Director Robert Lisicki resigned from board effective July 15, 2025, with no disagreement with the company.
- 2025 annual meeting scheduled for September 24, 2025; record date for voting is July 28, 2025.
- Shareholder proposals for proxy inclusion must be received by July 28, 2025; director nominations also due July 28.
- Universal proxy rule: shareholders soliciting proxies for director nominees must provide notice by July 28, 2025.

## SEC filing metadata
- accession: 0001213900-25-065710
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.08, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390025065710/0001213900-25-065710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390025065710/ea0249594-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-065710
- JSON: https://secwatch.observer/filing/0001213900-25-065710.json
- Plain text: https://secwatch.observer/filing/0001213900-25-065710.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.